QRS interval widening appears to be highly specific for the diagnosis of hyperkalemia in patients with end-stage kidney disease. ECG changes, in general, have poor sensitivities for hyperkalemia in ...

The ECG findings of hyperkalemia change as the potassium level increases. From earliest to latest, the ECG findings include: Peaked T waves best seen in the precordial leads, shortened QT interval and ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...

AliveCor has received approval from the Food and Drug Administration (FDA) to develop a non-invasive method of detecting high blood potassium levels. The startup, which chiefly focuses on monitoring ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device Designation by the U.S. Food and Drug Administration ...

NEW YORK, September 16, 2025--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ Guard TM, an FDA ...

The treatment of hyperkalemia can require urgent measures. Fortunately, it can usually be preemptively managed before serum K+ values become dangerously high. The urgency with which therapy is ...

This is quite an unusal ECG. The QRS morphology is unlike anything normally seen. Since it is upward concordent (all directed upward) in the precordial leads, which is one of the Brugada criteria for ...

AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ GuardTM, an FDA Breakthrough Device Designated AI-powered technology ...